Skip to main content
Log in

Potential antilipolytic activity of suloctidil

  • Kurze Originalmitteilungen
  • Medizin
  • Published:
Naturwissenschaften Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sulocton® [CP 556 S; 1-(4-isopropylthiophenyl)-2-n-octyl-amino-propanol], Continental Pharma S.A., Brussels, Belgium; Continental Pharma, Belgian Patents no739678 (1969) and no755688(1970)

  2. Adriaensen, H.: Current Ther. Research (submitted)

  3. Roba, J.,et al.: Continental Pharma report (to be published)

  4. Roncucci, R.,et al.: ibid. Continental Pharma report

  5. Peeters, H.,et al.: Nature (submitted)

  6. Gillot, P.: unpublished data

  7. Finger, K.F., Page, J.G., Feller, D.R.: Biochem. Pharmacol.15, 1023 (1966)

    Google Scholar 

  8. Blaton, V., Vandamme, D., Peeters, H.: FEBS Letters44, 185 (1974)

    Google Scholar 

  9. Duncombe, W.G.: Biochem. J.83, 6p (1962);88, 7 (1963); Clin. Chim. Acta8, 122 (1964)

  10. Muller, D.W., Allen, D.D.: Soc. Exp. Biol. Med.136 (3), 711 (1971); Andersson, R.,et al.: Atherosclerosis18, 399 (1973); Blackard, W.G., Kokatnur, M.G.: J. Atheroscler. Res.8, 189 (1968)

    Google Scholar 

  11. Dole, V.P.: J. Clin. Invest.,35, 150 (1956)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roncucci, R., Roba, J., Lambelin, G. et al. Potential antilipolytic activity of suloctidil. Naturwissenschaften 62, 141 (1975). https://doi.org/10.1007/BF00623284

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00623284

Keywords

Navigation